In the formulation of oral anti-foaming drenches for intensively finished beef cattle and high-producing dairy cows, Peregal O Veterinary Grade is used as a surface-active agent that lowers the surface tension of ruminal fluid below the point at which stable froth can persist. Published compendial monographs for liquid ruminant bloat drenches containing this exact polyoxyethylene oleyl ether grade are limited; the 10–25 wt% concentrate range reflects production-scale batch records for alcohol ethoxylate drench vehicles and must be confirmed for target-species efficacy in the intended market. The concentrate is prepared in a stainless-steel vessel with a low-shear hydrofoil impeller at 250–500 rpm and heated to 40–50°C before the addition of propylene glycol and potable water. After 30–45 min of mixing, the solution is filtered through an inline 100 µm strainer and filled into HDPE dosing containers. At administration, the concentrate is diluted at 1:20 to 1:50 with potable water to deliver approximately 2–4 g of surfactant per 450–600 kg adult bovine dose. Finished presentations from this line include ready-to-use oral drench liquids, metered-dose gun concentrates, and drinking-water medication concentrates for feedlot delivery. The finished veterinary medicinal product is subject to authorisation under Regulation (EU) 2019/6 in the European Union; if the surfactant is instead positioned as a technological feed additive, the legal basis is Regulation (EC) No 1831/2003, and the distinction must be resolved before labelling because the two routes impose different residue and withdrawal-period obligations. The main process boundary is storage above 45°C, where partial phase separation can occur in low-electrolyte concentrates, and the drench should not be combined with strong oxidising disinfectants in the same dosing line.

What Limits Autoclave Feasibility in Injectable Emulsions Containing Ethoxylated Oleyl Alcohol?

Steam sterilisation of an oil-in-water veterinary injectable emulsion prepared with Peregal O Veterinary Grade is governed by cloud-point behaviour and droplet-size growth, not by microbial lethality alone. The surfactant concentration is maintained at 0.5–1.5 wt% of the aqueous phase; below 0.5 wt%, coarse droplets larger than 1,000 nm appear after 5–10 min of high-shear processing at 10,000–15,000 rpm, while above 1.5 wt% the excess unbound surfactant raises the risk of hemolytic behaviour and contributes to endotoxin masking in the Limulus amebocyte lysate assay. The pre-emulsion is first prepared in a rotor-stator mixer and then passed through a high-pressure homogeniser at 500–900 bar for 3–5 passes to reach a median droplet size of 200–400 nm as measured by laser diffraction under ISO 13320:2020. Terminal sterilisation by autoclave is restricted to formulations whose cloud point exceeds 121°C in the presence of the chosen oil and electrolytes; if the cloud point falls below 115°C, the emulsion separates during the hold time, and aseptic filtration through a 0.22 µm membrane is required instead. Compliance testing follows Ph. Eur. 2.6.1 for sterility, Ph. Eur. 2.6.14 for bacterial endotoxins, and USP <788> for sub-visible particulate matter; for small-volume parenterals the acceptance criterion is ≤ 6,000 particles ≥ 10 µm per container and ≤ 600 particles ≥ 25 µm per container, while large-volume parenterals are assessed per millilitre. Peroxide content in the raw material must be controlled to ≤ 5 meq/kg because autoxidation products increase the free-radical load and can reduce vaccine antigen stability over 12–24 months at 2–8°C. Finished presentations that leave this line are injectable oil-in-water emulsions for sustained-release lipophilic veterinary drugs, adjuvanted vaccine emulsions, and reconstitutable injectable concentrates for on-farm dilution. The main incompatibility is with high concentrations of cationic preservatives in the aqueous phase, which can produce flocculation at autoclave temperatures.

For water-soluble oral powders incorporating hydrophobic coccidiostats, macrolide-class active substances, or sulfonamide combinations for swine and poultry, the main formulation constraint is slow wetting and lump formation when the dry mixture is added to drinking water at farm level. In a fluid-bed top-spray granulation line, Peregal O Veterinary Grade is dissolved in purified water at 5–12 wt% of the binder solution, and the solution is sprayed at 1.0–2.5 bar atomising pressure, an inlet air temperature of 55–70°C, and a spray rate of 8–15 g/min per kg of substrate charge. The resulting granule contains 0.1–0.5 wt% surfactant on a dry basis, which is sufficient to reduce the wetting time of a 5 g powder sample in 1 L of water at 15°C from more than 90 s to below 20 s in a USP <711> Apparatus II vessel at 50 rpm, without introducing foam that would complicate farm-level reconstitution. Batch-to-batch variance is controlled by monitoring product temperature at 30–38°C; excursions above 42°C produce waxy granule surfaces and poor flow through final sachet filling equipment. After drying, the granules are blended in an IBC blender at 6–10 rpm for 3–5 min. Regulatory file requirements for the finished powder include stability testing according to VICH GL1, moisture specification by USP <731>, and uniformity of dosage units by Ph. Eur. 2.9.40. The terminal product categories are water-soluble sachets, metering pump concentrates, and effervescent granule systems in which the surfactant acts as both wetting agent and de-dusting aid. The main operational boundary is relative humidity: premixes containing carbonate-bicarbonate effervescent pairs must be kept below 25% RH during granulation to prevent premature acid-base reaction, and the surfactant should not be pre-blended with strongly hygroscopic actives for more than 2 h before granulation.

Tablet and Bolus Wetting Is Governed by Binder-Solution HLB Rather Than Dry-Surfactant Loading

Because wet-granulation endpoint is defined by torque rather than fixed granulation time, high-shear processing of veterinary tablet and oral bolus blends containing Peregal O Veterinary Grade uses the ratio of surfactant to water in the granulating fluid as the primary control variable rather than dry-surfactant loading alone. A typical binder solution is prepared at 5–10 wt% surfactant, combined with pregelatinised starch or povidone, and added to a high-shear mixer-granulator at a total fluid volume of 8–15% w/w of the dry blend; the final dry surfactant concentration in the tablet is usually 0.5–1.5 wt%. Impeller speed is set to 200–500 rpm, chopper speed to 1,500–3,000 rpm, and the endpoint is determined by torque increase of 15–30% from the dry-mix baseline. The wet mass is passed through a 1.0–2.0 mm conical mill and dried in a fluid bed at 50–65°C until moisture reaches 1.5–2.5% by USP <731>. Compression on a rotary tablet press is performed at 8–25 kN with flat-faced bevelled tooling; tablet breaking force is evaluated using USP <1217>, with chewable veterinary tablets generally requiring 60–120 N to survive blister-pack ejection without fracturing while remaining chewable. For large ruminant boluses, compression force is increased to 20–35 kN to achieve 150–250 N breaking force, and the granule is diluted with microcrystalline cellulose to offset sticking to tooling when the surfactant content is at the upper limit. At surfactant additions above 1.5% w/w in the final dry formulation, tablet tensile strength can fall by more than 20–30% because the waxy ethoxylate films coat the binder bridges and reduce interparticulate bonding. Compliance endpoints include Ph. Eur. 2.9.5 for uniformity of mass of single-dose preparations, Ph. Eur. 2.9.40 for uniformity of dosage units, and Ph. Eur. 2.9.3 for dissolution testing. Finished presentations from this line are oral disintegrating tablets, chewable companion-animal tablets, and dense ruminant boluses intended for administration by balling gun. A processing incompatibility exists with high-moisture granulations above 20% w/w water in which anionic drugs form insoluble complexes with the nonionic surfactant at low pH; the granulating fluid pH should be maintained at 5.5–7.0 unless a formal compatibility study demonstrates otherwise.

When Capsule-Fill Granules Are Processed Above 30% Relative Humidity, Surfactant-Mediated Moisture Uptake Defines Dosator Performance

At relative humidity above 30–35% RH, encapsulation of hygroscopic granules on high-speed dosator machines used for companion-animal and equine formulations becomes sensitive to small changes in granule surface energy. Peregal O Veterinary Grade is incorporated at 0.3–1.5 wt% of the dry fill mass, usually via low-shear granulation in which the surfactant is dissolved in the binder fluid at 3–8 wt%. The granule is dried to a loss-on-drying value of 1.0–2.0% and passed through a 0.8–1.25 mm screen before encapsulation in size 0 or 1 hard gelatin or HPMC capsules. On a continuous capsule filler operating at 60,000–120,000 capsules/h, dosator compression force is set to 15–30 N; when relative humidity in the filling suite exceeds 30–35% RH, the granule surface becomes tacky, and ejection force from the dosator pin increases, causing weight variation to drift outside ±3% of target for low-fill-weight formulations below 100 mg. In production-scale campaigns, dry air at 18–22°C and 30% RH is maintained around the encapsulation machine, and the product hopper is flushed with nitrogen when the fill weight falls below 50 mg. Dissolution performance is assessed by USP <711> Apparatus II at 50–75 rpm in 900 mL of pH 6.8 phosphate buffer, where the surfactant reduces the lag time for hydrophobic actives by 10–30% compared with an untreated dry blend. Compliance endpoints include Ph. Eur. 2.9.1 disintegration time, with a limit of ≤ 15 min for immediate-release hard capsules, and Ph. Eur. 2.9.40 uniformity of dosage units. The final product types are immediate-release capsules for canine, feline, and equine patients, enteric-coated capsules where the surfactant is layered onto non-pareil seeds before film coating, and veterinary clinical study blind capsules where appearance neutrality is required. The main incompatibility is with high concentrations of divalent cations in the wet granulating fluid, which can reduce the cloud point and cause the surfactant to separate as a waxy film on granules during drying.

Premix Carrier Adsorption and Feed Pelleting Thermal Stability

In a feed mill producing 5–10 t/h of pelleted ruminant or swine feed, liquid Peregal O Veterinary Grade is converted into a flowable solid intermediate by spraying the liquid surfactant onto a hydrated calcium silicate or corn cob carrier in a ribbon blender. The liquid addition rate is typically 1–3 wt% of the carrier weight, and the spray is applied through a heated nozzle at 40–50°C to maintain viscosity below 100 mPa·s. The wetted carrier is blended for 5–10 min at 20–30 rpm, then mixed with the active premix to produce a final feed inclusion of 0.05–0.2 wt% surfactant in the complete feed. The diluted premix is added before pelleting, where conditioning at 80–90°C for 15–20 s and a pellet die temperature of 70–85°C can soften the surfactant and improve pellet durability, but prolonged retention above 90°C begins to reduce wetting function and may generate volatile degradation products. The premix feeder is calibrated to deliver 0.5–2.0 kg/ton of surfactant-containing premix, and pellet durability is measured by the tumbling box method under ASAE S269.4; production records typically maintain pellet durability index above 95% when the surfactant is pre-adsorbed onto a carrier rather than added as a liquid at the conditioner. The feed-additive dossier for the European Union falls under Regulation (EC) No 1831/2003, whereas medicated premixes for veterinary use are controlled under Regulation (EU) 2019/6 and relevant national withdrawal-period rules. Terminal presentations from this segment are 0.5–5% medicated premixes, water-soluble premix powders for milk replacers, and pelleted complete feeds containing hydrophobic active substances. The main operational boundary is moisture: the carrier should have a moisture content below 8% before liquid addition, and the finished premix should be packaged in polyethylene-lined sacks stored below 25°C to avoid compaction and caking.